Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Long-Term Debt Issuances (2016 - 2019)

Historic Long-Term Debt Issuances for ENDRA Life Sciences (NDRA) over the last 4 years, with Q3 2019 value amounting to $2.5 million.

  • ENDRA Life Sciences' Long-Term Debt Issuances changed N/A to $2.5 million in Q3 2019 from the same period last year, while for Dec 2020 it was $2.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.5 million for FY2019, which is 16627.83% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Long-Term Debt Issuances of $2.5 million as of Q3 2019.
  • In the past 5 years, ENDRA Life Sciences' Long-Term Debt Issuances ranged from a high of $2.5 million in Q3 2019 and a low of -$132000.0 during Q4 2016
  • Moreover, its 4-year median value for Long-Term Debt Issuances was $225000.0 (2017), whereas its average is $700749.9.
  • The largest annual percentage gain for ENDRA Life Sciences' Long-Term Debt Issuances in the last 5 years was 35000.0% (2017), contrasted with its biggest fall of 35000.0% (2017).
  • Over the past 4 years, ENDRA Life Sciences' Long-Term Debt Issuances (Quarter) stood at -$132000.0 in 2016, then soared by 270.45% to $225000.0 in 2017, then skyrocketed by 315.69% to $935300.0 in 2018, then skyrocketed by 166.28% to $2.5 million in 2019.
  • Its Long-Term Debt Issuances stands at $2.5 million for Q3 2019, versus $935300.0 for Q2 2018 and $225000.0 for Q1 2017.